保乳术后放射治疗的研究进展_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 李平 , 李燕

四川大学华西医院放疗科（成都 610041）;

Corresponding author：

李平, Email: leepingmd68@vip.163.com

Keywords：

DOI：

10.7507/1007-9424.201801092

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 李平, 李燕. 保乳术后放射治疗的研究进展. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2018, 25(2): 138-142. doi: 10.7507/1007-9424.201801092 Copy

1.	Zuo TT, Zheng RS, Zeng HM, et al. Female breast cancer incidence and mortality in China, 2013. Thorac Cancer, 2017, 8(3): 214-218.
2.	Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group. Lancet, 2000, 355(9217): 1757-1770.
3.	Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet, 2005, 366(9503): 2087-2106.
4.	Truong PT, Bernstein V, Lesperance M, et al. Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg, 2006, 191(6): 749-755.
5.	Early Breast Cancer Trialists’ Collaborative Group (EBCTCG); Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10, 801 women in 17 randomised trials. Lancet, 2011, 378(9804): 1707-1716.
6.	Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol, 2013, 24(9): 2206-2223.
7.	Voduc KD, Cheang MC, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 2010, 28(10): 1684-1691.
8.	Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol, 2011, 29(29): 3885-3891.
9.	Wo JY, Taghian AG, Nguyen PL, et al. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy. Int J Radiat Oncol Biol Phys, 2010, 77(1): 188-196.
10.	Crabb SJ, Cheang MC, Leung S, et al. Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer. Clin Breast Cancer, 2008, 8(3): 249-256.
11.	Houssami N, Macaskill P, Marinovich ML, et al. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol, 2014, 21(3): 717-730.
12.	Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages Ⅰ and Ⅱ invasive breast cancer. J Clin Oncol, 2014, 32(14): 1507-1515.
13.	Bartelink H, Maingon P, Poortmans P, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol, 2015, 16(1): 47-56.
14.	Poortmans P. Evidence based radiation oncology: breast cancer. Radiother Oncol, 2007, 84(1): 84-101.
15.	Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med, 2004, 351(10): 971-977.
16.	Kunkler IH, Williams LJ, Jack WJ, et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIMEⅡ): a randomised controlled trial. Lancet Oncol, 2015, 16(3): 266-273.
17.	Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med, 2004, 351(10): 963-970.
18.	Liu FF, Shi W, Done SJ, et al. Identification of a low-risk luminal a breast cancer cohort that may not benefit from breast radiotherapy. J Clin Oncol, 2015, 33(18): 2035-2040.
19.	Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol, 2013, 14(11): 1086-1094.
20.	Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med, 2010, 362(6): 513-520.
21.	Shaitelman SF, Schlembach PJ, Arzu I, et al. Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial. JAMA Oncol, 2015, 1(7): 931-941.
22.	Jagsi R, Griffith KA, Boike TP, et al. Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort. JAMA Oncol, 2015, 1(7): 918-930.
23.	Tanguturi SK, Bellon JR. Hypofractionation for early-stage breast cancer: no more excuses. JAMA Oncol, 2015, 1(7): 941-942.
24.	Njeh CF, Saunders MW, Langton CM. Accelerated partial breast irradiation (APBI): a review of available techniques. Radiat Oncol, 2010, 5: 90.
25.	Fastner G, Reitsamer R, Sedlmayer F. Partial breast irradiation with intraoperative electrons versus conventional external whole breast irradiation for early breast cancer. Results of the ELIOT trial. Strahlenther Onkol, 2014, 190(4): 422-424.
26.	Haverkamp U, Moustakis C. Calculation of the equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator. Strahlenther Onkol, 2014, 190(2): 235-236.
27.	Vaidya JS, Bulsara M, Wenz F, et al. Pride, prejudice, or science: attitudes towards the results of the TARGIT-A trial of targeted intraoperative radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys, 2015, 92(3): 491-497.
28.	Hepel J, Wazer DE. A flawed study should not define a new standard of care. Int J Radiat Oncol Biol Phys, 2015, 91(2): 255-257.
29.	Pawlik TM, Perry A, Strom EA, et al. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer, 2004, 100(3): 490-498.
30.	Leonardi MC, Maisonneuve P, Mastropasqua MG, et al. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys, 2012, 83(3): 806-813.
31.	Veronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol, 2013, 14(13): 1269-1277.
32.	Correa C, Harris EE, Leonardi MC, et al. Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol, 2017, 7(2): 73-79.
33.	Yang TJ, Tao R, Elkhuizen PH, et al. Tumor bed delineation for external beam accelerated partial breast irradiation: a systematic review. Radiother Oncol, 2013, 108(2): 181-189.
34.	Jöst V, Kretschmer M, Sabatino M, et al. Heart dose reduction in breast cancer treatment with simultaneous integrated boost: comparison of treatment planning and dosimetry for a novel hybrid technique and 3D-CRT. Strahlenther Onkol, 2015, 191(9): 734-741.
35.	Dellas K, Vonthein R, Zimmer J, et al. Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phaseⅡ trial (ARO-2010-01). Strahlenther Onkol, 2014, 190(7): 646-653.
36.	Ott OJ, Hildebrandt G, Pötter R, et al. Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence. Int J Radiat Oncol Biol Phys, 2011, 80(5): 1458-1463.
37.	Livi L, Meattini I, Marrazzo L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer, 2015, 51(4): 451-463.
38.	Rodríguez N, Sanz X, Dengra J, et al. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys, 2013, 87(5): 1051-1057.
39.	Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med, 2015, 373(4): 307-316.
40.	Jagsi R, Chadha M, Moni J, et al. Radiation field design in the ACOSOG Z0011 (Alliance) Trial. J Clin Oncol, 2014, 32(32): 3600-3606.
41.	Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med, 2015, 373(4): 317-327.

1. Zuo TT, Zheng RS, Zeng HM, et al. Female breast cancer incidence and mortality in China, 2013. Thorac Cancer, 2017, 8(3): 214-218.
2. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group. Lancet, 2000, 355(9217): 1757-1770.
3. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet, 2005, 366(9503): 2087-2106.
4. Truong PT, Bernstein V, Lesperance M, et al. Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg, 2006, 191(6): 749-755.
5. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG); Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10, 801 women in 17 randomised trials. Lancet, 2011, 378(9804): 1707-1716.
6. Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol, 2013, 24(9): 2206-2223.
7. Voduc KD, Cheang MC, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 2010, 28(10): 1684-1691.
8. Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol, 2011, 29(29): 3885-3891.
9. Wo JY, Taghian AG, Nguyen PL, et al. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy. Int J Radiat Oncol Biol Phys, 2010, 77(1): 188-196.
10. Crabb SJ, Cheang MC, Leung S, et al. Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer. Clin Breast Cancer, 2008, 8(3): 249-256.
11. Houssami N, Macaskill P, Marinovich ML, et al. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol, 2014, 21(3): 717-730.
12. Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages Ⅰ and Ⅱ invasive breast cancer. J Clin Oncol, 2014, 32(14): 1507-1515.
13. Bartelink H, Maingon P, Poortmans P, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol, 2015, 16(1): 47-56.
14. Poortmans P. Evidence based radiation oncology: breast cancer. Radiother Oncol, 2007, 84(1): 84-101.
15. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med, 2004, 351(10): 971-977.
16. Kunkler IH, Williams LJ, Jack WJ, et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIMEⅡ): a randomised controlled trial. Lancet Oncol, 2015, 16(3): 266-273.
17. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med, 2004, 351(10): 963-970.
18. Liu FF, Shi W, Done SJ, et al. Identification of a low-risk luminal a breast cancer cohort that may not benefit from breast radiotherapy. J Clin Oncol, 2015, 33(18): 2035-2040.
19. Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol, 2013, 14(11): 1086-1094.
20. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med, 2010, 362(6): 513-520.
21. Shaitelman SF, Schlembach PJ, Arzu I, et al. Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial. JAMA Oncol, 2015, 1(7): 931-941.
22. Jagsi R, Griffith KA, Boike TP, et al. Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort. JAMA Oncol, 2015, 1(7): 918-930.
23. Tanguturi SK, Bellon JR. Hypofractionation for early-stage breast cancer: no more excuses. JAMA Oncol, 2015, 1(7): 941-942.
24. Njeh CF, Saunders MW, Langton CM. Accelerated partial breast irradiation (APBI): a review of available techniques. Radiat Oncol, 2010, 5: 90.
25. Fastner G, Reitsamer R, Sedlmayer F. Partial breast irradiation with intraoperative electrons versus conventional external whole breast irradiation for early breast cancer. Results of the ELIOT trial. Strahlenther Onkol, 2014, 190(4): 422-424.
26. Haverkamp U, Moustakis C. Calculation of the equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator. Strahlenther Onkol, 2014, 190(2): 235-236.
27. Vaidya JS, Bulsara M, Wenz F, et al. Pride, prejudice, or science: attitudes towards the results of the TARGIT-A trial of targeted intraoperative radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys, 2015, 92(3): 491-497.
28. Hepel J, Wazer DE. A flawed study should not define a new standard of care. Int J Radiat Oncol Biol Phys, 2015, 91(2): 255-257.
29. Pawlik TM, Perry A, Strom EA, et al. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer, 2004, 100(3): 490-498.
30. Leonardi MC, Maisonneuve P, Mastropasqua MG, et al. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys, 2012, 83(3): 806-813.
31. Veronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol, 2013, 14(13): 1269-1277.
32. Correa C, Harris EE, Leonardi MC, et al. Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol, 2017, 7(2): 73-79.
33. Yang TJ, Tao R, Elkhuizen PH, et al. Tumor bed delineation for external beam accelerated partial breast irradiation: a systematic review. Radiother Oncol, 2013, 108(2): 181-189.
34. Jöst V, Kretschmer M, Sabatino M, et al. Heart dose reduction in breast cancer treatment with simultaneous integrated boost: comparison of treatment planning and dosimetry for a novel hybrid technique and 3D-CRT. Strahlenther Onkol, 2015, 191(9): 734-741.
35. Dellas K, Vonthein R, Zimmer J, et al. Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phaseⅡ trial (ARO-2010-01). Strahlenther Onkol, 2014, 190(7): 646-653.
36. Ott OJ, Hildebrandt G, Pötter R, et al. Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence. Int J Radiat Oncol Biol Phys, 2011, 80(5): 1458-1463.
37. Livi L, Meattini I, Marrazzo L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer, 2015, 51(4): 451-463.
38. Rodríguez N, Sanz X, Dengra J, et al. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys, 2013, 87(5): 1051-1057.
39. Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med, 2015, 373(4): 307-316.
40. Jagsi R, Chadha M, Moni J, et al. Radiation field design in the ACOSOG Z0011 (Alliance) Trial. J Clin Oncol, 2014, 32(32): 3600-3606.
41. Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med, 2015, 373(4): 317-327.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

保乳术后放射治疗的研究进展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content